Success Stories: An Instructor in the Field of Biomedical Science from Hong Kong is Helped by NAILG’s Team to Get NIW Approval Without RFE
Client’s Testimonial:
“NAILG provided professional and expedient service when putting together my NIW petition. They were always quick when answering my questions provided invaluable advice and guidance through the petitioning process.”
On August 23rd, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an Instructor in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Instructor
Country of Origin: Hong Kong
State of Residence at the Time of Filing: Illinois
Approval Notice Date: August 23rd, 2022
Processing Time: 14 months, 26 days
Case Summary:
An expert in the field of biomedical science, our client from Hong Kong was working as an instructor in the field when he came to us seeking help with his NIW (National Interest Waiver) petition. He wanted to continue his research on how the immune system behaves in skin cancers and identify new mutations that drive their formation to develop new therapies against them.
Our team of experts could easily see that his research had great substantial merit and national importance. This was necessary proof for NIW approval shown by the fact that his work was relevant to cancer research as well as autoimmune and inflammatory bowel disease treatment, medical technology, and public health worldwide. This was why one of his 4 recommenders said the following:
“In sum, [the client] is a highly pragmatic, highly influential researcher compelling innovation in the field of biomedical science. As made evident here, his findings are beneficial for the medical and healthcare sectors and the fight against cancer.”
On the other hand, our team collected other relevant data for his case such as his publication and citation count, his major funding sources, etc. We were thus able to show that his research has resulted in 13 peer-reviewed journal articles (4 of them first-authored) and these papers have been published in no fewer than 10 highly ranked peer-reviewed journals. At the same time, these publications have been cited a total of 298 times according to Google Scholar.
We also showed that he had received at least 5 major financial aid from institutes such as the National Institutes of Health, the National Institute of Diabetes and Digestive and Kidney Diseases, etc. Therefore, another favorable recommender said:
“Breastcancer.org estimates that about 1 in 8 women will develop invasive breast cancer throughout her lifetime. These statistics are alarming, necessitating the work of researchers like [the client], who research the mechanisms responsible for cancer progression, including the molecular mediators of breast cancer metastasis… Hence, the research conducted by [the client] has tremendous national benefit as it not only helps in advancing the field of biomedical science but also leads to the betterment of public health in the United States and across the world.”
We are grateful to the USCIS for his NIW approval, and we take this opportunity to thank our team of experts and once again congratulate our client on this victory. Also, we wish our client success in all his future endeavors.